实用肝脏病杂志 ›› 2011, Vol. 14 ›› Issue (1): 37-38.doi: 10.3969/j.issn.1672-5069.2011.01.014

• 论著 • 上一篇    下一篇

立体定向放射治疗原发性肝癌伴下腔静脉癌栓的疗效评价

季洪兵,吕光明   

  1. 350025 福州市 南京军区福州总医院肿瘤放射治疗中心
  • 收稿日期:2010-08-24 出版日期:2011-02-10 发布日期:2016-04-15
  • 通讯作者: 吕光明,E-mail:brightLGMing@hotmail.com
  • 作者简介:季洪兵 男,36岁,硕士研究生,主治医师。主要从事肿瘤放射治疗研究。E-mail:fjjhb8@sina.com

Efficacy of stereotactic conformal therapy in the treatment of patients with hepatocellular carcinoma with tumor thrombus in inferior vena cava

JI Hongbing,LV Guangming   

  1. Center of Radiation Oncology,Military General Hospital,Fuzhou 350025,China
  • Received:2010-08-24 Online:2011-02-10 Published:2016-04-15

摘要: 目的 评价立体定向放疗治疗肝细胞癌伴下腔静脉癌栓的疗效。方法 在66例肝细胞癌伴下腔静脉癌栓患者中,36例接受立体定向放射治疗,30例未接受放射治疗。结果 36例接受伽玛刀治疗的癌栓患者,12例(33.3%)癌栓完全缓解,10例(27.8%)部分缓解,13例(36.1%)稳定,1例(2.8%)进展。癌栓治疗有效率为61.1%,1年生存率为27.8%,中位生存期为9.8个月;未放疗的30例患者1年生存率为11.5%,中位生存期为3.5个月。多因素分析显示,放疗组病人生存情况与肝内病灶单多发有关。Child-Pugh分级是影响预后的主要因素。结论 立体定向放射治疗可明显延长肝细胞癌伴有下腔静脉癌栓患者的生存期。

关键词: 肝细胞癌, 立体定向放射治疗, 下腔静脉癌栓

Abstract: Objective To evaluate the effects of stereotactic conformal therapy(SCT)in the treatment of patients with hepatocellular carcinoma with tumor thrombus in inferior vena cava. Methods 66 hepatocellular carcinoma patients with tumor thrombus in inferior vena cava were reviewed and analyzed by Kaplan-Meier and Cox regression analysis. 36 patients with tumor thrombus in inferior vena cava with hepatocellular carcinoma were treated with stereotactic conformal therapy(body gamma knife),and 30 patients did not receive stereotactic conformal therapy. The planned target volume was encompassed by 50% to 70% isodose line,and tumor dose was 3Gy to 4Gy per fraction,with total dose ranging from 30Gy to 48Gy. Results In 36 patients with stereotactic conformal therapy,12(33.3%)were in complete remission,10(27.8%)in partial remission,13(36.1%)were in no change, and 1(2.8%)showed disease progression. The remission rate of tumor thrombus in inferior vena cava was 61.1% and one-year survival rate was 27.8% with the median survival of 9.8 months. In the non-SCT-treated 30 patients,one-year survival rate was 11.5% and the median survival was 3.5 months. Cox proportional hazards model analysis showed that the number of tumors and Child-Pugh class were the independent prognostic factor for the survival probability of the patients. Conclusion The stereotactic conformal radiotherapy is an effective method for treatment of tumor thrombus in inferior vena cava in patients with hepatocellular carcinoma.

Key words: Hepatocellular carcinoma, Stereotactic conformal therapy, Inferior vena cava, Thrombus